David R Epstein Insider Trading $RUBY Rubius Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David R Epstein.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David R Epstein. David R Epstein is Director in INTERNATIONAL FLAVORS & FRAGRANCES INC ($IFF) and Director in Molecular Insight Pharmaceuticals, Inc. ($MIPI) and Director in Axcella Health Inc. ($AXLA) and Director in Evelo Biosciences, Inc. ($EVLO) and Director in Rubius Therapeutics, Inc. ($RUBY).
David R Epstein in Rubius Therapeutics, Inc.
Trading Symbol: RUBYIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of David R Epstein: Director
Holdings: 4,690,012 shares
Latest Transaction: May 13 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of David R Epstein in Rubius Therapeutics, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AXLA, EVLO, IFF, MIPI, RUBY
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2021 | RUBY | Rubius Therapeutic ... | Epstein David R | Director | Option Exercise | A | 23.25 | 27,919 | 649,117 | 27,919 | |
Feb 16 2021 | RUBY | Rubius Therapeutic ... | Epstein David R | Director | Sell | S | 14.93 | 26,704 | 398,560 | 4,690,012 | 4.7 M to 4.7 M (-0.57 %) |
Feb 10 2021 | RUBY | Rubius Therapeutic ... | Epstein David R | Director | Sell | S | 14.79 | 7,404 | 109,525 | 4,716,716 | 4.7 M to 4.7 M (-0.16 %) |
Feb 10 2021 | RUBY | Rubius Therapeutic ... | Epstein David R | Director | Sell | S | 14.83 | 2,100 | 31,146 | 4,724,120 | 4.7 M to 4.7 M (-0.04 %) |
Feb 10 2021 | RUBY | Rubius Therapeutic ... | Epstein David R | Director | Sell | S | 14.88 | 89,233 | 1,328,117 | 4,726,220 | 4.8 M to 4.7 M (-1.85 %) |
May 26 2020 | RUBY | Rubius Therapeutic ... | Epstein David R | Director | Option Exercise | A | 6.22 | 115,771 | 720,096 | 115,771 | |
Mar 19 2020 | RUBY | Rubius Therapeutic ... | Epstein David R | Director | Buy | P | 3.76 | 5,000 | 18,800 | 4,815,453 | 4.8 M to 4.8 M (+0.10 %) |
Mar 17 2020 | RUBY | Rubius Therapeutic ... | Epstein David R | Director | Buy | P | 4.00 | 5,000 | 20,000 | 4,810,453 | 4.8 M to 4.8 M (+0.10 %) |
Mar 17 2020 | RUBY | Rubius Therapeutic ... | Epstein David R | Director | Buy | P | 3.82 | 5,000 | 19,100 | 4,805,453 | 4.8 M to 4.8 M (+0.10 %) |
May 28 2019 | RUBY | Rubius Therapeutic ... | Epstein David R | Director | Option Exercise | A | 16.27 | 39,094 | 636,059 | 39,094 | |
Jul 18 2018 | RUBY | Rubius Therapeutic ... | Epstein David R | Director | Option Exercise | A | 23.00 | 1,902,977 | 43,768,471 | 1,902,977 |
Page: 1